In addition, our results of the longitudinal samples showed the increased expression of PDCD1 and CD274 only in the post-trastuzumab tumor (Figure 6D), supporting the notion that PD-1 expression is an indicator of trastuzumab response. Here, PDCD1 is linked to neoplasm.